HIV therapeutic vaccine enhances non-exhausted CD4+ T cells in a randomised phase 2 trial
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HIV therapeutic vaccine enhances non-exhausted CD4+ T cells in a randomised phase 2 trial
Authors
Keywords
-
Journal
npj Vaccines
Volume 4, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-06-03
DOI
10.1038/s41541-019-0117-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Revisiting the Functional Impact of NK Cells
- (2018) Aurélie Poli et al. TRENDS IN IMMUNOLOGY
- Systemic DPP4 activity is reduced during primary HIV-1 infection and is associated with intestinal RORC+ CD4+ cell levels: a surrogate marker candidate of HIV-induced intestinal damage
- (2018) Mickaël J Ploquin et al. Journal of the International AIDS Society
- HIV
- (2018) Jade Ghosn et al. LANCET
- Durability of viral suppression with first-line antiretroviral therapy in patients with HIV in the UK: an observational cohort study
- (2017) Jemma O'Connor et al. Lancet HIV
- Polyfunctional HIV-specific T cells in Post-Treatment Controllers
- (2016) Assia Samri et al. AIDS
- Treatment intensification followed by interleukin-7 reactivates HIV without reducing total HIV DNA
- (2016) Christine Katlama et al. AIDS
- Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system
- (2016) C. Klemann et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Perspectives for immunotherapy: which applications might achieve an HIV functional cure?
- (2016) Vincent Vieillard et al. Oncotarget
- CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART
- (2016) Rémi Fromentin et al. PLoS Pathogens
- Influence of the Timing of Antiretroviral Therapy on the Potential for Normalization of Immune Status in Human Immunodeficiency Virus 1–Infected Individuals
- (2015) Jason F. Okulicz et al. JAMA Internal Medicine
- Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration
- (2014) Colette J Smith et al. LANCET
- NK Cell Activation in Human Hantavirus Infection Explained by Virus-Induced IL-15/IL15Rα Expression
- (2014) Monika Braun et al. PLoS Pathogens
- Identification of a cellular ligand for the natural cytotoxicity receptor NKp44
- (2013) F. Baychelier et al. BLOOD
- CD4+T-cell depletion in HIV infection: mechanisms of immunological failure
- (2013) Afam A. Okoye et al. IMMUNOLOGICAL REVIEWS
- Designing Tomorrow's Vaccines
- (2013) Gary J. Nabel NEW ENGLAND JOURNAL OF MEDICINE
- Evaluation of vaccine-induced antibody responses: Impact of new technologies
- (2013) Daniel J. Zaccaro et al. VACCINE
- Specific Anti-gp41 Antibodies Predict HIV-1 Disease Progression
- (2012) Vincent Vieillard et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Revealing the role of CD4+T cells in viral immunity: Figure 1.
- (2012) Andrea J. Sant et al. JOURNAL OF EXPERIMENTAL MEDICINE
- An HIVgp41 vaccine protects CD4 central memory T cells in SHIV-infected macaques
- (2012) Vincent Vieillard et al. VACCINE
- Pathogenic Mechanisms of HIV Disease
- (2011) Susan Moir et al. Annual Review of Pathology-Mechanisms of Disease
- Responsiveness of HIV-specific CD4 T cells to PD-1 blockade
- (2011) F. Porichis et al. BLOOD
- Transcutaneous and intradermal vaccination
- (2011) Behazine Combadiere et al. Human vaccines & immunotherapeutics
- Immune reconstitution after a decade of combined antiretroviral therapies for human immunodeficiency virus
- (2011) Amélie Guihot et al. TRENDS IN IMMUNOLOGY
- In vivo expansion of naive and activated CD4+CD25+FOXP3+ regulatory T cell populations in interleukin-2-treated HIV patients
- (2010) L. Weiss et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- HIV escape from natural killer cytotoxicity: nef inhibits NKp44L expression on CD4+ T cells
- (2009) Hugues Fausther-Bovendo et al. AIDS
- Incomplete Peripheral CD4+Cell Count Restoration in HIV‐Infected Patients Receiving Long‐Term Antiretroviral Treatment
- (2009) Colleen F. Kelley et al. CLINICAL INFECTIOUS DISEASES
- Interleukin-2 Therapy in Patients with HIV Infection
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- A vaccine strategy against AIDS: An HIV gp41 peptide immunization prevents NKp44L expression and CD4+ T cell depletion in SHIV-infected macaques
- (2008) V. Vieillard et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started